tradingkey.logo


tradingkey.logo


Apyx Medical Corp

APYX
3.580USD
-0.060-1.65%
終倀 03/30, 16:00ET15分遅れの株䟡
63.10M時䟡総額
損倱額盎近12ヶ月PER


詳现情報 Apyx Medical Corp 䌁業名

Apyx Medical Corporation is an advanced energy technology company. The Company's segments include Advanced Energy and Original Equipment Manufacturer (OEM). The Advanced Energy segment's product portfolio consists of Helium Plasma Technology, which is marketed and sold as Renuvion in the cosmetic surgery market, and J-Plasma in the hospital surgical market. It focuses on the cosmetic surgery market, where Renuvion offers plastic surgeons, facial plastic surgeons and cosmetic physicians the ability to provide controlled heat to the tissue to achieve their desired results. These product lines consist of a multifunction generator, a handpiece and a supply of helium gas. Through OEM agreements, the OEM segment produces generators, medical devices, and related accessories for medical device manufacturers as well as start-up businesses in need of its energy-based designs. It specializes in the design, development, and manufacturing of electrosurgical equipment and medical devices.

Apyx Medical Corpの䌁業情報


䌁業コヌドAPYX
䌚瀟名Apyx Medical Corp
䞊堎日Jul 22, 1983
最高経営責任者「CEO」Goodwin (Charles D)
埓業員数220
蚌刞皮類Ordinary Share
決算期末Jul 22
本瀟所圚地5115 Ulmerton Rd
郜垂CLEARWATER
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜United States of America
郵䟿番号33760-4004
電話番号18005372790
りェブサむトhttps://apyxmedical.com/
䌁業コヌドAPYX
䞊堎日Jul 22, 1983
最高経営責任者「CEO」Goodwin (Charles D)

Apyx Medical Corpの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
1.75M
--
Mr. Moshe Citronowicz
Mr. Moshe Citronowicz
Senior Vice President
Senior Vice President
493.50K
+7.50%
Mr. Lawrence J. (Larry) Waldman, CPA
Mr. Lawrence J. (Larry) Waldman, CPA
Lead Independent Director
Lead Independent Director
42.90K
--
Mr. Shawn David Roman
Mr. Shawn David Roman
Chief Operating Officer
Chief Operating Officer
12.00K
--
Mr. Matthew C. (Matt) Hill
Mr. Matthew C. (Matt) Hill
Chief Financial Officer, Treasurer, Secretary
Chief Financial Officer, Treasurer, Secretary
8.50K
--
Mr. Charles D. Goodwin, II
Mr. Charles D. Goodwin, II
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Minnie Baylor-Henry, J.D.
Ms. Minnie Baylor-Henry, J.D.
Independent Director
Independent Director
--
--
Ms. Wendy Levine
Ms. Wendy Levine
Independent Director
Independent Director
--
--
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
1.75M
--
Mr. Moshe Citronowicz
Mr. Moshe Citronowicz
Senior Vice President
Senior Vice President
493.50K
+7.50%
Mr. Lawrence J. (Larry) Waldman, CPA
Mr. Lawrence J. (Larry) Waldman, CPA
Lead Independent Director
Lead Independent Director
42.90K
--
Mr. Shawn David Roman
Mr. Shawn David Roman
Chief Operating Officer
Chief Operating Officer
12.00K
--
Mr. Matthew C. (Matt) Hill
Mr. Matthew C. (Matt) Hill
Chief Financial Officer, Treasurer, Secretary
Chief Financial Officer, Treasurer, Secretary
8.50K
--
Mr. Charles D. Goodwin, II
Mr. Charles D. Goodwin, II
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--

収益内蚳

通貚: USD曎新時刻: Tue, Jan 6
通貚: USD曎新時刻: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
䌚瀟から関連デヌタがただ開瀺されおいたせん。
地域別USD
䌚瀟名
収益
比率
Domestic
9.33M
72.47%
International
3.54M
27.53%
事業別
地域別
䌚瀟から関連デヌタがただ開瀺されおいたせん。

株䞻

曎新時刻: Sun, Mar 15
曎新時刻: Sun, Mar 15
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
Nantahala Capital Management, LLC
9.83%
Archon Capital Management LLC
7.68%
Vanderfelt (William Weeks)
7.55%
Royce Investment Partners
5.84%
Vizirgianakis (Stavros G)
4.17%
他の
64.92%
株䞻統蚈
株䞻統蚈
比率
Nantahala Capital Management, LLC
9.83%
Archon Capital Management LLC
7.68%
Vanderfelt (William Weeks)
7.55%
Royce Investment Partners
5.84%
Vizirgianakis (Stavros G)
4.17%
他の
64.92%
皮類
株䞻統蚈
比率
Hedge Fund
19.52%
Individual Investor
13.27%
Investment Advisor
12.35%
Investment Advisor/Hedge Fund
11.31%
Private Equity
1.93%
Research Firm
0.80%
Family Office
0.18%
Pension Fund
0.08%
他の
40.57%

機関投資家保有株


曎新時刻: Mon, Dec 8
曎新時刻: Mon, Dec 8
報告期間
機関投資家数
保有株匏数
比率
倉動額
2025Q4
93
15.65M
47.11%
--
2025Q3
106
16.17M
54.10%
-179.30K
2025Q2
111
16.35M
54.58%
+38.20K
2025Q1
115
16.92M
61.27%
-6.24M
2024Q4
121
17.05M
55.05%
+3.13M
2024Q3
126
13.93M
65.05%
-228.66K
2024Q2
141
15.10M
68.01%
-305.66K
2024Q1
168
15.41M
70.58%
-9.04M
2023Q4
180
18.49M
72.63%
-941.37K
2023Q3
175
19.43M
74.54%
-988.75K
詳现を芋る

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
Nantahala Capital Management, LLC
3.34M
8.14%
--
--
Sep 30, 2025
Archon Capital Management LLC
3.28M
8%
--
--
Sep 30, 2025
Vanderfelt (William Weeks)
3.16M
7.7%
--
--
Jun 23, 2025
Royce Investment Partners
2.47M
6.03%
+34.70K
+1.42%
Sep 30, 2025
Vizirgianakis (Stavros G)
1.75M
4.26%
--
--
Jun 23, 2025
The Vanguard Group, Inc.
1.53M
3.73%
+53.17K
+3.60%
Sep 30, 2025
Silverberg Bernstein Capital Management, LLC
986.50K
2.41%
+89.77K
+10.01%
Sep 30, 2025
Commonwealth Financial Network
663.54K
1.62%
--
--
Sep 30, 2025
Horizon Kinetics LLC
615.00K
1.5%
--
--
Sep 30, 2025
詳现を芋る

関連ETF


曎新時刻: Sat, Dec 6
曎新時刻: Sat, Dec 6
銘柄名
比率
iShares Micro-Cap ETF
0.02%
Avantis US Equity ETF
0%
Avantis US Small Cap Equity ETF
0%
iShares Micro-Cap ETF
比率0.02%
Avantis US Equity ETF
比率0%
Avantis US Small Cap Equity ETF
比率0%

配圓金


過去5幎間の配圓金総支払額は 0.00 米ドルである。
日付
配圓金
暩利確定日
支払日
配圓萜ち日
デヌタなし

株匏分割


日付
配圓萜ち日
皮類
比率
デヌタなし
日付
配圓萜ち日
皮類
比率
デヌタなし
KeyAI
î™